Translate Bio Inc (TBIO)

NASDAQ
17.50
-0.50(-2.78%)
  • Volume:
    634,382
  • Bid/Ask:
    17.47/17.53
  • Day's Range:
    16.45 - 17.93

TBIO Overview

Prev. Close
18
Day's Range
16.45 - 17.93
Revenue
138.81M
Open
17.04
52 wk Range
11.91 - 34.62
EPS
-0.3
Volume
634,382
Market Cap
1.34B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,193,349
P/E Ratio
-
Beta
-
1-Year Change
24.14%
Shares Outstanding
75,232,798
Next Earnings Date
Aug 12, 2021
What is your sentiment on Translate Bio Inc?
or
Vote to see community's results!

Translate Bio Inc News

Translate Bio Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellBuy
Technical IndicatorsSellStrong SellStrong SellStrong SellBuy
SummarySellStrong SellStrong SellStrong SellBuy

Translate Bio Inc Company Profile

Translate Bio Inc Company Profile

Employees
122

Translate Bio, Inc. is a messenger RNA, or mRNA, therapeutics company. The Company is developing medicines to treat diseases caused by protein or gene dysfunction. The Company is using its proprietary mRNA therapeutic platform, or MRT platform, and it create mRNA that encodes functional proteins. The mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. The MRT product candidate for the lung, MRT5005, is designed to address the underlying cause of CF by delivering mRNA encoding fully functional CFTR protein to the lung epithelial cells through nebulization.

Read More
  • 17.5
    1
    • Sanofi to restart trial of covid vaccine after facing delays🚀🚀🚀
      0
      • 🚀🚀🚀lets go
        0
        • it's going back up again or I should take the loss and sell it?
          1
          • what happened with this company? Anyone knows it?
            0
            • Sanofi is backing them
              0
            • 👍 Then Im in
              0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.